Maynard
0
Maynard Paton | BIOVENTIX: H1 2025 Revenue Up Just 1% Due To ‘Mature’ Markets Leaves £24 Shares Yielding 6%-Plus And Future Growth Seemingly Dependent On Promising Alzheimer’s R&D And Associated Royalty/Supply Arrangements
0

Apologies! This BVXP H1 2025 review has taken somewhat longer than expected to produce. BVXP’s FY 2025 results are due tomorrow (27 October) and to ...

0
Maynard Paton | MOUNTVIEW ESTATES: 17% Fewer Disposals And Fourth Consecutive Sub-60% Annual Gross Margin — With A Particularly Weak H2 — Cuts FY 2025 Profit By 15% And Leaves £92 Shares Yielding 5.7% And Trading 11% Below NAV
0

Apologies! This MTVW FY 2025 review has taken somewhat longer than expected to produce. MTVW’s subsequent H1 2026 results were published on Thursday ...

0
Maynard Paton | [ShareScope] Small-Cap Spotlight Report: SCIENCE GROUP
0

***ShareScope New Subscriber Special Offer*** Readers of my blog can enjoy a 20% first-year discount! Click here for details >> 23 November ...

0
Maynard Paton | S & U: FY 2024 Confirms 41% H2 Profit Slump And 17% Final-Dividend Cut After Enhanced ‘Forbearance’ Regulations Prompt 74% Impairment Surge And Collections To Slide To A Pandemic-Like 69%
0

19 September 2024By Maynard Paton FY 2024 results summary for S & U (SUS): A very disappointing FY, with H2 profit slumping 41% and the ...

0
Maynard Paton | [SharePad] Screening For My Next Long-Term Winner: CASTINGS
0

***ShareScope New Subscriber Special Offer*** Readers of my blog can enjoy a 20% first-year discount! Click here for details >> 19 September ...

0
Maynard Paton | TRISTEL: New Chief Exec’s Financial Targets Keenly Awaited After Record H1 2024 Announces 30% UK Growth, 100% Dividend Jump, Bumper 84% Gross Margin And ‘$100m Opportunity’ In North America
0

01 October 2024By Maynard Paton H1 2024 results summary for Tristel (TSTL): A record H1, displaying revenue up 20%, profit up 28% and the ...

0
Maynard Paton | Q3 2024: Running Multi-Baggers To 40% (Or More!) Of Your Portfolio
0

03 October 2024By Maynard Paton Happy Thursday! I trust your shares have been keeping up with this year’s rising FTSE. A summary of my ...

0
Maynard Paton | [SharePad] Small-Cap Spotlight Report: SOFTWARE CIRCLE
0

***ShareScope New Subscriber Special Offer*** Readers of my blog can enjoy a 20% first-year discount! Click here for details >> 12 October ...

0
Maynard Paton | BIOVENTIX: Record H1 2024 Reveals Profit Up 15% Despite Slowing Troponin Growth As Encouraging Alzheimer’s Work Attracts ‘Significant Attention’ And Research-Test Availability Through Quanterix
0

22 October 2024By Maynard Paton H1 2024 results summary for Bioventix (BVXP): A record H1, showing revenue up 13%, profit up 15% and the ...

Som2ny Network
Logo
Compare items
  • Total (0)
Compare
0
Shopping cart